Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/30/2012CN102475890A Acceptor protein, and coding gene and application thereof
05/30/2012CN102475885A 肝细胞生长因子制剂在生发中的应用 Hepatocyte growth factor in the formulation used in the germinal
05/30/2012CN102475884A 四个多肽在制备ace抑制剂及降血压药物中的应用 The four peptides used in the preparation of ace inhibitors and antihypertensive drugs in
05/30/2012CN102475721A Probiotics oral liquid for health promotion
05/30/2012CN102475718A 禽用转移因子可溶性粉剂及其制作工艺和质量检验方法 Avian transfer factor soluble powder with its production process and quality inspection methods
05/30/2012CN102475636A 模拟细胞外基质的脂肪来源干细胞的干细胞性增进用组合物 Simulation of the extracellular matrix of the adipose-derived stem cells Stem cells promotion composition
05/30/2012CN102078304B Insulin drug carried microspheres and preparation method thereof
05/30/2012CN101933949B Application of traditional Chinese medicine medicated leaven in lysozyme-liposome coated with chitosan
05/30/2012CN101921326B Recombinant decorsin mutant, preparation method and application thereof
05/30/2012CN101824406B Recombinant beta-lactamase-RGD-fusion protein and application thereof in medicine
05/30/2012CN101757610B Application of snake venom cytotoxin -CTX1 in the preparation of drugs with analgesic function
05/30/2012CN101735307B Platelet envelope glycoprotein oligopeptide or trim/derivate thereof and application thereof
05/30/2012CN101575379B Soluble VEGFR difunctional fusion receptors, preparation method and use thereof
05/30/2012CN101568351B Controlled release composition and process
05/30/2012CN101559218B Composition with function of increasing bone density
05/30/2012CN101547935B Interferon alpha mutant and its polyethylene glycol derivative
05/30/2012CN101537170B Compound for preventing osteoporosis and osteoarthrosis
05/30/2012CN101519663B Recombinant CREG protein and application thereof
05/30/2012CN101492711B Uses of MAGEA9 gene
05/30/2012CN101456901B 12 peptide ZA for inhibiting hepatitis c virus to infect human cell and preparation method and application
05/30/2012CN101443022B Use of a growth-stimulating protein
05/30/2012CN101426516B Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
05/30/2012CN101402675B Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides
05/30/2012CN101297033B Debriding composition from bromelain and methods of production thereof
05/30/2012CN101248085B Polypeptides having antimicrobial activity and polynucleotides encoding same
05/30/2012CN101181227B Solid lipid nanometer particle in-situ gel rubber preparations of biological adherent cyclosporine A and preparation method thereof
05/30/2012CN101155596B Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
05/30/2012CN101102789B Diagnosis and treatment of Alzheimer's disease
05/30/2012CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
05/30/2012CN101002549B Transgenic non-human animals capable of producing heterologous antibodies
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188254 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/29/2012US8188247 Conjugates and compositions for cellular delivery
05/29/2012US8188246 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use
05/29/2012US8188236 Eta-1 gene and methods for use
05/29/2012US8188230 Method for recombinant microorganism expression and isolation of collagen-like polypeptides
05/29/2012US8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
05/29/2012US8188226 High activity growth factor mutants
05/29/2012US8188222 High molecular weight derivative of nucleic acid antimetabolite
05/29/2012US8188219 Cyclic peptide for use in diagnosis, prevention and treatment of bone disorders
05/29/2012US8188218 Bi-functional peptides for multiple sclerosis treatment and diagnosis
05/29/2012US8188216 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents
05/29/2012US8188215 Metal-binding compounds and uses therefor
05/29/2012US8188214 Brachyury polypeptides and methods for use
05/29/2012US8188213 Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI)
05/29/2012US8188151 Methods for treating diabetes
05/29/2012US8188147 Administering a urea cycle intermediate, citrulline; preventing hyperammonemia
05/29/2012US8188065 Boldine compounds for promoting bone growth
05/29/2012US8188058 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
05/29/2012US8188056 Utilizing nucleic acid expression constructs that are delivered into a subject and express stable therapeutic proteins in vivo
05/29/2012US8188053 Anti-inflammatory peptides
05/29/2012US8188052 Method for the treatment and prevention of ocular disorders
05/29/2012US8188051 Metadherin polypeptides, encoding nucleic acids and methods of use
05/29/2012US8188050 Pharmaceutical and/or cosmetic composition containing peptides
05/29/2012US8188049 Peptides having activities of epidermal growth factor and its uses
05/29/2012US8188048 Combination therapy
05/29/2012US8188046 Amyloid beta peptides and methods of use
05/29/2012US8188045 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
05/29/2012US8188044 Anti-tumor drug, medicament, composition, and use thereof
05/29/2012US8188043 Nicotine in therapeutic angiogenesis and vasculogenesis
05/29/2012US8188042 Nanoparticles for protein drug delivery
05/29/2012US8188041 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
05/29/2012US8188040 FGF21 mutants and uses thereof
05/29/2012US8188038 Osteogenic compositions containing a coloring agent
05/29/2012US8188037 Microparticles comprising somatostatin analogues
05/29/2012US8188034 Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
05/29/2012US8188033 Anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity
05/29/2012US8188032 G-CSF transferrin fusion proteins
05/29/2012US8187881 Methods related to wound healing
05/29/2012US8187874 Drug discovery method
05/29/2012US8187855 Large-scale production of soluble hyaluronidase
05/29/2012US8187828 Use of PAK inhibitor for the treatment of a joint disease
05/29/2012US8187819 Methods of identifying compounds that bind TANGO240
05/29/2012US8187817 Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies
05/29/2012US8187672 Residual solvent extraction method and microparticles produced thereby
05/29/2012US8187625 Cross-linked gelatin composition comprising a wetting agent
05/29/2012US8187619 Enhanced compositions containing cells and extracellular matrix materials
05/29/2012US8187616 Method for silk fibroin gelation using sonication
05/29/2012US8187615 Non-aqueous compositions for oral delivery of insoluble bioactive agents
05/29/2012US8187614 Method of using lectins for prevention and treatment of oral and alimentary tract disorders
05/29/2012US8187613 Method of treating allergies using TGF-β1 and allergens
05/29/2012US8187612 Neuromuscular disorders
05/29/2012US8187611 Anti-peptide antibodies that cross react with protective antigen of Bacillus anthracis and uses thereof
05/29/2012US8187608 Treatment of Fibrosis related disorders
05/29/2012US8187605 Means for the inhibition of anti-β1-adrenergic receptor antibodies
05/29/2012US8187600 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
05/29/2012US8187599 Compositions and methods for suppressing fibrocytes
05/29/2012US8187598 Methods of treating cancer by administering antibodies to CD200
05/29/2012US8187597 Combination therapy for the treatment of ocular neovascular disorders
05/29/2012US8187592 C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
05/29/2012US8187591 Methods of treating coagulopathy
05/29/2012US8187587 Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
05/29/2012US8187586 Methods of inducing apoptosis in hyperproliferative cells
05/29/2012US8187584 Human tumor necrosis factor-α mutants
05/29/2012CA2557910C Methods of reducing aggregation of il-1ra
05/29/2012CA2516016C Hepatitis c inhibiting compounds
05/29/2012CA2514584C Peptide inhibitors of toxins derived from ll-37
05/29/2012CA2483214C Wound dressings comprising hydrated hydrogels and enzymes
05/29/2012CA2455403C Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/29/2012CA2448218C Sustained release formulation
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 3163